Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate RxSight, Inc. before investing.

In this article, we go over a few key elements for understanding RxSight, Inc.’s stock price such as:

• RxSight, Inc.’s current stock price and volume
• Why RxSight, Inc.’s stock price changed recently
• Upgrades and downgrades for RXST from analysts
• RXST’s stock price momentum as measured by its relative strength

About RxSight, Inc. (RXST)

Before we jump into RxSight, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Want to learn more about RxSight, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about RxSight, Inc..

RxSight, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, RxSight, Inc.’s stock price was $6.010.

RxSight, Inc. is down 1.15% from its previous closing price of $6.080.

During the last market session, RxSight, Inc.’s stock traded between $5.860 and $6.120. Currently, there are approximately 41.31 million shares outstanding for RxSight, Inc..

RxSight, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

RxSight, Inc. Stock Price History

RxSight, Inc.’s (RXST) price is currently up 24.69% so far this month.

During the month of July, RxSight, Inc.’s stock price has reached a high of $6.220 and a low of $4.805.

Over the last year, RxSight, Inc. has hit prices as high as $13.220 and as low as $4.480. Year to date, RxSight, Inc.’s stock is down 42.32%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused RxSight, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded RxSight, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate RxSight, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on RxSight, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

RxSight, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about RxSight, Inc. (RXST) by visiting AAII Stock Evaluator.

Relative Price Strength of RxSight, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, RxSight, Inc. has a weighted four-quarter relative price strength of -10.90%, which translates to a Momentum Score of 22 and is considered to be Weak.

Want to learn more about how RxSight, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

RxSight, Inc. Stock Price: Bottom Line

As of July 31, 2026, RxSight, Inc.’s stock price is $6.010, which is down 1.15% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like RxSight, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.